MarketInOut Stock Screener Log In | Sign Up
 

NeoGenomics Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/23/2026
NeoGenomics Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,104.43 mln
Float126 mln
Earnings Date10/28/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.63
Likely reliable

1-Year Forecast

21.85
Strong upside

Relative Strength

77 / 100
Strongly outperforming

Debt / Equity

0.57
Moderate leverage

Pre-Tax Margin

-7%
Marginally loss-making

Business Description

NeoGenomics is a specialized cancer testing company with laboratories across the United States and United Kingdom. It serves a wide range of clients, including hospitals, oncologists, and pharmaceutical companies, providing them with detailed analysis of cancer cells, genes, and tissue samples. This work helps doctors make accurate diagnoses and supports drug companies in developing and bringing new cancer treatments to market. Founded in 2001 and based in Fort Myers, Florida, the company plays an important role in advancing cancer care.

Key Fundamentals

EPS-0.39
ROE-6.26
RPS5.94
ROIC-4.38
ROA-3.80
Interest Cover-25.64
EBITDA, mln13.49
EV / EBITDA200
EV / EBIT-52.04
Revenue, mln766
EV / Revenue3.53

Quote Details

Last 16.59
Change 0.2 (1.22%)
Open 16.36
Volume 1,430,722
Turnover 23,735,678
Average Volume 2,139,623

Financial Ratios

Pre-Tax Profit Margin-7
Leverage Ratio1.72
Current Ratio3.60
Price / Book2.99
Price / Cash Flow96.36
Debt / Equity0.57
Price / Sales3.09
PEG Ratio2.09

Financial Strength

Altman Z-Score2.77
Piotroski F-Score 5 / 9
Beneish M-Score-2.63
Price to Intrinsic Value19.51
1-Year Target Price21.85
Short Ratio6.99
Short % of Float13.00

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.36% 44 / 100   
1 Month -15.18% 23 / 100   
2 Months 16.5% 91 / 100   
6 Months 100% 98 / 100   
1 Year 60.44% 94 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog